Titanium and cobalt-chromium alloys are widely used for orthopaedic and craniomaxillofacial implants. However, they often require secondary operations for removal if complications occur or are no longer needed. Conversely, magnesium (Mg) and its alloys are biodegradable, biocompatible, and beneficial for bone growth, and provide mechanical properties similar to cortical bone. However, pure Mg degrades too rapidly for clinical applications. Here, we created Mg-based bioresorbable implants (B6 implants) with delayed degradation and enhanced stability and bioactivity. This in vivo study demonstrated the degradation process and osteogenic and inflammatory responses to B6 implants in comparison with relevant controls.